"Un afectuoso y cordial saludo a todos nuestros usuarios que nos siguen a través de nuestra página web; en mi calidad de Director del Hospital Central FAP es oportuno el agradecimiento en primer orden a DIOS por su cuidado y dirección, al Comandante General de la FAP por la confianza depositada al nombrarme como Director y en tercer orden a mi Familia por apoyarme en todo."

During the past decade, Hospital Central FAP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Central FAP" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Central FAP" are "Cancer" (1 trials), "Coronavirus Disease 2019" (1 trials), "Head and Neck Cancer" (1 trials), "Lung Cancer" (1 trials) and "Squamous Cell Cancer" (1 trials). Many other conditions were trialed in "Hospital Central FAP" in a lesser frequency.

Most popular intervention types in "Hospital Central FAP" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Carrimycin" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "PF-00299804" (1 trials) and "Zalutumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Central FAP" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Central FAP". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Central FAP, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Central FAP, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".